Print

OXiGENE (OXGN) Reports Third Quarter 2012 Financial Results  
11/9/2012 10:09:26 AM

SOUTH SAN FRANCISCO, Calif., Nov. 8, 2012 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, reported financial results for the quarter and nine months ending September 30, 2012.
//-->